Search Results

AZD5363 50mg 50mg  | Purity Not Available

Adooq Bioscience

AZD5363 is a potent inhibitor of AKT with pharmacodynamic activity in vivo, has potential to treat a range of solid and hematologic tumors as monotherapy or a combinatorial agent.

More Information Supplier Page

AZD5363 5mg 5mg  | Purity Not Available

Adooq Bioscience

AZD5363 is a potent inhibitor of AKT with pharmacodynamic activity in vivo, has potential to treat a range of solid and hematologic tumors as monotherapy or a combinatorial agent.

More Information Supplier Page

AZD5363 25mg 25mg  | Purity Not Available

Adooq Bioscience

AZD5363 is a potent inhibitor of AKT with pharmacodynamic activity in vivo, has potential to treat a range of solid and hematologic tumors as monotherapy or a combinatorial agent.

More Information Supplier Page

AZD5363 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

AZD5363 is a potent inhibitor of AKT with pharmacodynamic activity in vivo, has potential to treat a range of solid and hematologic tumors as monotherapy or a combinatorial agent.

More Information Supplier Page

AZD5363 10mg 10mg  | Purity Not Available

Adooq Bioscience

AZD5363 is a potent inhibitor of AKT with pharmacodynamic activity in vivo, has potential to treat a range of solid and hematologic tumors as monotherapy or a combinatorial agent.

More Information Supplier Page

GSK126 5mg 5mg  | Purity Not Available

Adooq Bioscience

GSK126 is a potent, highly selective, S-adenosyl-methionine-competitive, small-molecule inhibitor of EZH2 methyltransferase activity, decreases global H3K27me3 levels and reactivates silenced PRC2 target genes.

More Information Supplier Page

MK-2461 10mg 10mg  | Purity Not Available

Adooq Bioscience

MK-2461, a novel multitargeted kinase inhibitor, preferentially inhibits the activated c-Met receptor.

More Information Supplier Page